Sarepta Therapeutics buy BiotechBee
Start price
29.10.23
/
50%
€15.21
Target price
31.03.26
€150.00
Performance (%)
-
End price
30.10.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sarepta Therapeutics | 11.144% | 11.144% | -83.478% |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% |
According to BiotechBee what are the pros and cons of Sarepta Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year